Aduhelm

The Veterans Health Administration (VHA) said it will widely cover an experimental $26,500-per-year Alzheimer’s…

Conceptual illustration showing an elderly person with progressive impairments of brain functions.getty The FDA’s…

The Food and Drug Administration’s (FDA) process for approving a controversial Alzheimer’s drug with…

Traffic light with yellow light on, signal for proceed with caution.getty This article is the fifth installment in…

For a number of years, the price of drugs has drawn extraordinary attention. Based on the current discourse, one…

Progressives are criticizing the Biden administration’s recent announcement that the 2022 Medicare premium will…

Health and Human Services Secretary Xavier Becerra announced on Friday that Medicare premiums would be adjusted…

Jay Reinstein, 60, diagnosed with Alzheimer's disease, in Raleigh, North Carolina, U.S., on ...…

Biogen slashed the price of its controversial new Alzheimer’s drug Aduhelm on Monday as the drug faces weak sales…

Safety data from those trials was published Monday in the journal JAMA Neurology in a study whose authors included…